PRKCD and cerebrovascular disorder: In cerebrovascular diseases, PKCδ induces abnormal phosphorylation of endothelial barrier proteins, undermining vascular integrity and exacerbating cerebral hemorrhage and cell damage; targeted inhibition of PKCδ can reverse BBB disruption [311, 312].